OHP’s unique CBD is designed as a full spectrum cannabidiol that has been shown to positively affect more than 1,200 genes to promote health and longevity. Six hundred and eighty “gene transcripts” are upregulated (“turned on”) by cannabidiol and 524 are downregulated (“turned off”) to exert marked anti-oxidant and anti-inflammatory effects.
Recent studies indicate that this full spectrum CBD influences the expression of some genes by directly activating PPAR-gamma, a receptor situated on the cell’s nucleus that has widespread health benefits when activated. Peroxisome proliferator activated receptors , “PPARs”, are triggered by hormones, endogenous fatty acids, and various nutritional compounds. When activated, PPARs bind to certain segments of DNA to promote or prevent transcription of specific genes.
Many of the genes regulated by PPARs are involved in energy balance, lipid uptake and metabolism, insulin sensitivity, and other essential metabolic functions.
Not only does OHP full spectrum CBD hemp oil contain high levels of cannabidiol, it also contains vitamins, nutrients, minerals, volatile acids, and antioxidants that will further supplement your health.
After extensive testing of over thirty variants, extractions, carriers, and producers we found the best of the best 100% organically grown, Colorado single-origin cultivator. We also use the finest quality, and fewest possible ingredients and carrier oils such as fractionated coconut, medium chain triglyceride (MCT) oil.
OHP CBD contains only two ingredients, full-spectrum, high CBD extract and fair trade, certified organic MCT oil, nothing more, nothing less.We believe this is such an important adjunct to genetic health modification that we have priced it to be affordable to all our clients.
Ingredients:1 fl oz/30ml vial 750mg Organic MCT Fractionated Coconut Oil Organically Grown Full Spectrum Hemp Extract 24.99mg† of Hemp oil extract per serving 30 servings per container †daily value not established
- Ament Z, et al, “Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs)...” Genome Medicine,” 2012.
- Biscetti F, et al, “Peroxisome proliferator-activated receptors and angiogenesis,” Nutrition, Metabolism & Cardiovascular Diseases, 2009.
- Chearwae W and Bright JJ, “PPAR-gamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells,”British Journal of Cancer, 2008.
- Costa M, et al, “Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-alpha gene (PPARA)...,” European Psychopharmacology, 2012.
- Esposito G, et al, “Cannabidiol reduces amyloid beta-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR-gamma involvement,” PLOS One, 2011.
- Juknat, A, et al, “Cannabidiol affects the expressions of genes involved in zinc homeostasis in BV-2 microglial cells,”Neurochemical International, 2011.
- Ramer R, et al. “COX-2 and PPAR-gamma confer cannabidiol-induced apoptosis of human lung...,” American Association for Cancer Research (AARC), 2012.
- Rovito D, et al, “Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARg activation...,” Journal of Cellular Physiology, 2013.
- Song M, et al, “Modulation... pathophysiology by natural medicines through PPAR-g-related pharmacology,” British Journal of Pharmacology, 2012.
- Sugden M, et al, “PPAR control: it’s SIRTainly as easy as PCG,” Journal of Endocrinology, 2010.
- Treacy, MP and Hurst, TP, “The case for intraocular delivery of PPAR agonists...,”BMC Opthalmology, 2012.